Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects

New evidence that human telomerase RNA (hTR) degradation by EXOSC10 or DCP2 and XRN1 reduces telomerase activity when dyskerin is compromised suggests that RNA decay pathways may provide future therapeutic targets for telomere biology disorders.